Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Single Daily Trientine for Wilson Disease Maintenance
NCT01472874Phase 2Completed
- Sponsor
- Yale University
- Start
- Jan 2010
- Primary completion
- Jul 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of trientine in Wilson disease (WD), sponsored by Yale University. Started Jan 2010; status: completed.
02
Drugs
trientine
03
Conditions
Wilson disease (WD)
Beyond the preview
Go deeper on NCT01472874.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01472874.